Maximino Redondo
Maximino Redondo
Afiliación desconocida
Dirección de correo verificada de
Citado por
Citado por
Overexpression of clusterin in human breast carcinoma
M Redondo, E Villar, J Torres-Munoz, T Tellez, M Morell, CK Petito
The American journal of pathology 157 (2), 393-399, 2000
Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia
C Marchal, M Redondo, M Padilla, J Caballero, I Rodrigo, J Garcia, ...
Histology and histopathology, 2004
Presence of HPV 16 sequences in laryngeal carcinomas
M Perez‐Ayala, F Ruiz‐Cabello, F Esteban, A Concha, M Redondo, ...
International journal of cancer 46 (1), 8-11, 1990
Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus
E Matas-Rico, B García-Diaz, P Llebrez-Zayas, D López-Barroso, L Santín, ...
Molecular and Cellular Neuroscience 39 (3), 342-355, 2008
Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters
M Redondo, A Concha, R Oldiviela, A Cueto, A Gonzalez, F Garrido, ...
Cancer research 51 (18), 4948-4954, 1991
NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2
M Muñoz, M Rosso, FJ Aguilar, MA González-Moles, M Redondo, ...
Investigational new drugs 26 (2), 111-118, 2008
Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease
JA Morales-Garcia, M Redondo, S Alonso-Gil, C Gil, C Perez, A Martinez, ...
PloS one 6 (2), e17240, 2011
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
R Perez-Gonzalez, C Pascual, D Antequera, M Bolos, M Redondo, ...
Neurobiology of aging 34 (9), 2133-2145, 2013
PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury
I Paterniti, E Mazzon, C Gil, D Impellizzeri, V Palomo, M Redondo, ...
PLoS One 6 (1), e15937, 2011
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model
M Redondo, JG Zarruk, P Ceballos, DI Pérez, C Pérez, A Perez-Castillo, ...
European journal of medicinal chemistry 47, 175-185, 2012
Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis
M Redondo, J Garcı́a, E Villar, I Rodrigo, E Perea-Milla, A Serrano, ...
Human pathology 34 (12), 1283-1289, 2003
Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer
C Marchal, M Redondo, A Reyes-Engel, E Perea-Milla, MJ Gaitan, ...
European Journal of Surgical Oncology (EJSO) 34 (7), 805-810, 2008
Expression of substance P and neurokinin‐1‐receptor in laryngeal cancer: linking chronic inflammation to cancer promotion and progression
F Esteban, MA Gonzalez‐Moles, D Castro, M Del Mar Martin‐Jaen, ...
Histopathology 54 (2), 258-260, 2009
bcl-2 Expression and apoptosis in primary and metastatic breast carcinomas
E Villar, M Redondo, I Rodrigo, J García, E Avila, A Matilla
Tumor biology 22 (3), 137-145, 2001
The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
M Muñoz, R Coveñas, F Esteban, M Redondo
Journal of biosciences 40 (2), 441-463, 2015
Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy …
M Redondo, T Téllez, MJ Roldan, A Serrano, M García-Aranda, ...
Breast Cancer Research 9 (6), 1-8, 2007
Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation
M Redondo, F Ruiz-Cabello, A Concha, T Cabrera, M Perez-Ayala, ...
Cancer research 51 (9), 2463-2468, 1991
Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds
M Redondo, J Brea, DI Perez, I Soteras, C Val, C Perez, ...
Journal of medicinal chemistry 55 (7), 3274-3284, 2012
Clusterin expression is associated with decreased disease‐free survival of patients with colorectal carcinomas
M Redondo, I Rodrigo, J Alcaide, T Tellez, MJ Roldan, R Funez, ...
Histopathology 56 (7), 932-936, 2010
Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers
L Domingo, J Blanch, S Servitja, JM Corominas, C Murta-Nascimento, ...
European journal of cancer prevention 22 (1), 21-28, 2013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20